The Impact of a Home-based Pulmonary Telerehabilitation Program in Acute Exacerbations of COPD
Pulmonary Disease, Chronic Obstructive
About this trial
This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring pulmonary disease, chronic obstructive, pulmonary rehabilitation, muscle atrophy
Eligibility Criteria
Inclusion Criteria:
- Veterans
- Moderate or severe COPD with a forced expiratory volume in 1 second - forced vital capacity ratio (FEV1/FVC) < 0.70 and FEV1 < 80% predicted
- Hospitalization with a primary diagnosis of AECOPD, defined as an increase in shortness of breath, cough, and/or sputum production beyond the normal day-to-day variation necessitating a change in regular medication when other causes of increased shortness of breath, cough, and/or sputum production have been ruled out
- Capable of operating a tablet independently with adequate vision and hearing
Exclusion Criteria:
- Acute hypercapneic respiratory failure with a requirement for either non-invasive (i.e. bilevel positive airway pressure) or invasive mechanical ventilation during hospitalization
- Hospitalization < 72 hours
- A secondary diagnosis of acute congestive heart failure, myocardial infarction, or pneumonia during hospitalization or unstable cardiac or neurologic disease at discharge
- Enrollment in a pulmonary rehabilitation program within 12 months of hospitalization
A medical condition that makes exercise unsafe (includes upper and lower limb strength training and lower limb cycle ergometry)
- This will be determined by the following- screen for these through chart review, discussion with the patient (do they have any known cardiac issues, do they have chest pain with exertion, are they lightheaded with exertion), discussion with the physicians caring for the patient in the hospital, and direct observation and assessment during the bedside pulmonary rehab sessions (that were built into this study for safety purposes)
- Inclusion in another greater than minimal risk study
Sites / Locations
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Pulmonary Telerehabilitation Intervention Group
Usual Care Group
The intervention will consist of an eight-week, three sessions per week, home-based pulmonary telerehabilitation program that will incorporate both lower extremity endurance exercise and upper and lower extremity resistance training. Subjects randomized to the study intervention will also participate in a one hour, twice-monthly support group via group video conferencing consisting of an educational topic (i.e. inhaler use, understanding COPD) and group discussion.
Participants randomized to the usual care arm will also be enrolled in our institution's telehealth program, will receive an automatic blood pressure monitor, portable pulse oximeter, and scale and will be in regular contact with a telehealth provider. A study team member will meet with participants randomized to the usual care arm to discuss the importance of exercise and will encourage exercise (strength training, light aerobic activity such as walking or cycling) a minimum of 20-40 minutes three times per week at discharge.